GACM
BLUE

Green Arrow Capital Management’s bluebird bio BLUE Stock Holding History

Green Arrow Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,860
Closed -$1.93M – 180
2014
Q2 		$1.93M Sell
3,860
-772
-17% -$247K 0.24% 102
2014
Q1 		$1.36M Buy
4,632
+2,316
+100% +$702K 0.12% 174
2013
Q4 		$629K Buy
+2,316
New +$647K 0.04% 231

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Green Arrow Capital Management's BLUE Position: Q3 2014 in Review

Green Arrow Capital Management sold out of bluebird bio (BLUE) in Q3 2014, closing a stake of 3,860 shares — an estimated $1.93M sold.

Green Arrow Capital Management first reported a position in BLUE in Q4 2013 and held it in 3 quarters. The position peaked at $1.93M in Q2 2014. 123 funds tracked by Wall St. Rank hold BLUE as of Q3 2014.

  • Green Arrow Capital Management reported no remaining bluebird bio position as of Q3 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 3,860 bluebird bio shares in Q3 2014, an estimated $1.93M.
  • Green Arrow Capital Management first reported a position in bluebird bio in Q4 2013 and held it in 3 quarters.
  • Green Arrow Capital Management's bluebird bio position peaked at $1.93M in Q2 2014.
  • 123 funds tracked by Wall St. Rank held bluebird bio as of Q3 2014.

Based on Green Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.